PharmExPrep

Syllabus

CMCaP Prep Course (CMCaP)

87 lessons. Online and self-paced.

ECS And Cannabis Science

Foundational science for the endocannabinoid system, phytocannabinoids, minor cannabinoids, terpenes, and product composition. Emphasis is on core mechanisms that support later clinical decision-making.

  1. 1ECS Components And Enzymes
  2. 2CB1 Versus CB2 Roles
  3. 3ECS Homeostasis And Signaling
  4. 4THC And CBD Pharmacology
  5. 5Minor Cannabinoids And Terpenes
  6. 6Ensemble Effect Theory
  7. 7Chemovars And Product Profiles
  8. 8Full Spectrum Product Types
  9. 9Natural Synthetic And Biosynthetic Cannabinoids
  10. 10Novel Delivery Technologies
  11. 11Illicit Synthetic Cannabinoid Risks

Pharmacokinetics And Interactions

High-yield pharmacokinetics, pharmacogenomics, detection, and interaction management for cannabis-related therapies. Focus is on route differences, metabolism, and medication safety screening.

  1. 12Route Specific PK Profiles
  2. 13First Pass THC Metabolism
  3. 14Lipophilicity And Tissue Distribution
  4. 15CYP And Variant Relevance
  5. 16Personalized Dosing Considerations
  6. 17Detection Windows And Counseling
  7. 18CYP Mediated Interaction Patterns
  8. 19Pharmacodynamic Sedation Risks
  9. 20Medication Profile Interaction Screen
  10. 21Interaction Monitoring And Communication

Evidence Based Therapeutics

Critical appraisal and patient-specific application of cannabis evidence across major symptom domains. Emphasis is on quality of evidence, limitations, and role-appropriate recommendations.

  1. 22Neuropathic And Nociceptive Pain
  2. 23THC CBD Roles In Pain
  3. 24Opioid Sparing Evidence Limits
  4. 25Pain Monitoring And Follow Up
  5. 26CBD In Seizure Disorders
  6. 27MS Spasticity And Palliative Care
  7. 28CINV And Appetite Support
  8. 29Chemotherapy And Immunotherapy Precautions
  9. 30Anxiety PTSD And Sleep Data
  10. 31Psychosis Bipolar And Destabilization
  11. 32Harm Reduction In Psychiatry
  12. 33Trial Design And Blinding Challenges
  13. 34Observational Data And Registries
  14. 35Marketing Claims Versus Evidence
  15. 36Patient Specific Evidence Translation

Assessment And Care Planning

Structured pharmacist assessment of eligibility, risk, shared decision-making, and follow-up planning within legal and professional boundaries.

  1. 37History Medication And Substance Review
  2. 38Contraindications And High Risk Flags
  3. 39Qualifying Condition Verification Boundaries
  4. 40Shared Decision Making Elements
  5. 41PROMs And Symptom Diaries
  6. 42Follow Up And Escalation Triggers

Products Dosing And Quality

Practical product selection, route choice, titration strategy, calculations, and quality assurance concepts for pharmacist review.

  1. 43Inhaled Oral And Topical Forms
  2. 44Novel Formulation Considerations
  3. 45Route Selection By Care Goal
  4. 46Cannabinoid Ratio Selection
  5. 47Patient Preference And Prior Response
  6. 48Reputable Source Verification
  7. 49Start Low Go Slow
  8. 50Potency Unit Interpretation
  9. 51Supply Estimation And Dose Checks
  10. 52Titration Troubleshooting Cases
  11. 53Certificate Of Analysis Review
  12. 54Contamination And Quality Risks
  13. 55Storage And Stability Counseling

Safety And Harm Reduction

Adverse effects, impairment, misuse risk, substance use disorder, and patient-centered counseling for safer cannabis use.

  1. 56Common THC Adverse Effects
  2. 57Driving And Safety Counseling
  3. 58Cannabinoid Hyperemesis Recognition
  4. 59Adverse Effect Response Plan
  5. 60Cannabis Use Disorder Criteria
  6. 61Dependence Tolerance And Addiction
  7. 62Motivational Interviewing For Risk
  8. 63Diversion Prevention Strategies
  9. 64Safe Storage And Handling
  10. 65Stigma Equity And Communication
  11. 66Liability And Ethical Boundaries

Communication And Documentation

Interprofessional communication, documentation quality, workflow verification, and safety reporting in cannabis-related pharmacy practice.

  1. 67Recommendation Framing For Clinicians
  2. 68Cannabis Subject Matter Communication
  3. 69Conflict And Disagreement Management
  4. 70Assessment And Intervention Notes
  5. 71Minimum Necessary Information Use
  6. 72Error Near Miss Reporting
  7. 73Order And Profile Plausibility
  8. 74Calculation And Conversion Checks
  9. 75Best Next Step Prioritization

Policy And Professional Practice

Public health, legal conflicts, program compliance, advocacy, and risk management for cannabis pharmacy practice. Emphasis remains on lawful, role-appropriate professional action.

  1. 76Federal State Conflict Basics
  2. 77Approved Cannabinoids Versus Cannabis
  3. 78Role Appropriate Legal Counseling
  4. 79Program Requirement Verification
  5. 80PDMP And Controlled Substance Review
  6. 81Audit Ready Recordkeeping
  7. 82Community Risk Mitigation
  8. 83Opioid Harm Reduction Context
  9. 84Policy Advocacy And Leadership
  10. 85Professional Liability Risk Control
  11. 86Continuous Quality Improvement Systems
  12. 87Recalls Audits And Crisis Plans
PharmExPrep
Programs
For organizations
ContactLog inGet a free guide